REFINE YOUR SEARCH
Type of document
|Date||Ref.||Title||Section||Type||Download||Info||Summary||Related Documents||Translated versions|
|11/07/2018||ESMA70-145-941||Introductory statement for ECON scrutiny session on Level 2 measures under the EU Benchmarks Regulation||Market Integrity||Statement||PDF
|08/06/2017||ESMA70-145-104||Introductory statement for ECON meeting on level 2 Measures under the Benchmarks Regulation (BMR)||Market Integrity||Statement||PDF
|08/07/2022||ESMA35-43-3137||ESMA presents the results of the 2021 Common Supervisory Action (CSA) on MiFID II product governance requirements||MiFID - Investor Protection, Supervisory convergence||Statement||PDF
|13/07/2021||ESMA35-43-2749||ESMA Public Statement PFOF and zero-commission brokers||MiFID - Investor Protection||Statement||PDF
|21/07/2021||ESMA35-43-2748||Public statement- Results of the 2020 Common Supervisory Action (CSA) on MiFID II suitability requirements||MiFID - Investor Protection||Statement||PDF
|31/03/2021||ESMA35-43-2632||Application of the temporary suspension of the obligation to publish RTS 27 reports||MiFID - Investor Protection||Statement||PDF
|13/01/2021||ESMA35-43-2509||Reminder to firms of the MiFID II rules on ‘reverse solicitation’ in the context of the recent end of the UK transition period||Brexit, MiFID - Investor Protection||Statement||PDF
|29/03/2021||ESMA35-43-2430 Final Report ESMA’s Technical Advice to the Commi||Technical Advice on the application of administrative and criminal sanctions under MiFID II/MiFIR||MiFID - Investor Protection||Technical Advice||PDF
|06/05/2020||ESMA35-43-2391||Reminder of firms’ MiFID II conduct of business obligations in the context of increasing retail investor activity||COVID-19, MiFID - Investor Protection||Statement||PDF
|20/03/2020||ESMA35-43-2348||ESMA Statement on COVID-19 telephone recording||COVID-19, MiFID - Investor Protection||Statement||PDF
|04/02/2020||ESMA35-43-2134||ESMA’s Technical Advice to the Commission on the effects of product intervention measures||MiFID - Investor Protection||Technical Advice||PDF
|01/04/2020||ESMA35-43-2126||Technical Advice on the impact of the inducements and costs and charges disclosure requirements under MiFID II||MiFID - Investor Protection||Technical Advice||PDF
|19/12/2018||ESMA35-43-1328||Brexit Statement- information to clients||Brexit, MiFID - Investor Protection||Statement||PDF
|28/06/2017||ESMA35-36-885||Product Intervention- General Statement||Innovation and Products, MiFID - Investor Protection||Statement||PDF
This statement provides an update on the European Securities and Markets Authority’s (ESMA) work in relation to the sale of contracts for differences (CFDs), binary options and other speculative products to retail investors.
ESMA has been concerned about the provision of speculative products such as CFDs, rolling spot forex and binary options to retail investors for a considerable period of time and has conducted ongoing monitoring and supervisory convergence work in this area. In this context, ESMA has previously published a number of Q&As on CFDs and other speculative products to foster supervisory convergence, having established a CFD Task Force in July 2015, and also issued a further investor warning on the sale of CFDs, binary options and other speculative products in July 2016.
However, ESMA remains concerned that these supervisory convergence tools may not be sufficiently effective to ensure that the risks to consumer protection are sufficiently controlled or reduced. ESMA is therefore discussing the possible use of its product intervention powers under Article 40 of MiFIR to address investor protection risks in relation to CFDs, rolling spot forex and binary options.
ESMA is in the process of discussing the possible use of its product intervention powers under Article 40 of MiFIR, the possible content of any such measures, and how they could be applied. However, ESMA can confirm that the measures being discussed for (i) CFDs and rolling spot forex and (ii) binary options include proposals that take into account a number of measures that have been adopted or publicly consulted on by EU National Competent Authorities. These measures include leverage limits, guaranteed limits on client losses, and / or restrictions on the marketing and distribution of these products.
In accordance with Article 40 of MiFIR, any intervention measures must be approved by the ESMA Board of Supervisors and can only come into effect from 3 January 2018 at the earliest.
 ESMA/2016/1166 Warning about CFDs, binary options and other speculative products published 25 July 2016
|31/03/2020||ESMA35-36-1919||Clarification of issues related to the publication of reports by execution venues and firms as required under RTS 27 and 28||COVID-19, MiFID - Investor Protection||Statement||PDF
|12/07/2019||ESMA35-36-1743||Statement Product Intervention||MiFID - Investor Protection||Statement||PDF
|20/05/2020||ESMA32-63-972||Implications of the COVID-19 outbreak on the half-yearly financial reports||Corporate Disclosure, COVID-19||Statement||PDF
|25/03/2020||ESMA32-63-951||Accounting implications of the COVID-19 outbreak on the calculation of expected credit losses in accordance with IFRS 9||Corporate Disclosure, COVID-19||Statement||PDF
|22/10/2019||ESMA32-63-791||European common enforcement priorities for 2019 annual financial reports||Corporate Disclosure, IAS Regulation||Statement||PDF
|26/10/2018||ESMA32-63-503||European common enforcement priorities for 2018 annual financial reports||Corporate Disclosure, IFRS Supervisory Convergence||Statement||PDF